Search

everythinglearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

Urologists prescribe newer medications more often than primary care physicians, who could benefit from more education on treatment options.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Amlodipine impairs fertility in male rats by affecting sperm and testicular structure.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Finasteride weakens the bone-protective effects of certain blockers in low androgen conditions.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Age and other health issues affect erectile dysfunction more than finasteride or alpha-blockers.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Alpha-blocker therapy may not be needed long-term when combined with finasteride for BPH.

The inhibitor affects androgen metabolism but not ovarian function.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Minoxidil and nebivolol can help prevent aortic aging in diabetic mice.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

Blocking adenosine A2B receptor may prevent or treat hearing loss.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.